Target and non-target effects of a recombinant vaccinia-rabies virus developed for fox vaccination against rabies.
Pastoret
P P
PP
Department of Immunology-Vaccinology, Faculty of Veterinary Medicine, University of Liège, Belgium.
Brochier
B
B
Boulanger
D
D
D000818:Animals; D000835:Animals, Wild; D005589:Foxes; D005822:Genetic Vectors; D009928:Organ Specificity; D011818:Rabies / Q000517:prevention & control*; D011819:Rabies Vaccines / Q000009:adverse effects / Q000235:genetics / Q000494:pharmacology*; D011820:Rabies virus / Q000235:genetics* / Q000502:physiology; D011995:Recombination, Genetic; D012449:Safety; D014614:Vaccines, Synthetic / Q000009:adverse effects / Q000235:genetics / Q000494:pharmacology*; D014616:Vaccinia virus / Q000235:genetics* / Q000502:physiology; D014779:Virus Replication
D011819:Rabies Vaccines; D014614:Vaccines, Synthetic